$64.33+1.21 (+1.92%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Vita Coco (COCO) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~12.6%/yr (FY21→FY25), net margin 11.7%; free cash flow runs at 55% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+10.7%) and Capex step-up ($8.1M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲18.2%
609.8
FY21→FY25CAGR +12.6%/yr
Net income ($M)▲27.5%
71.3
FY21→FY25CAGR +39.2%/yr
Free cash flow ($M)▼6.9%
39.0
capex stepped upCAGR —
Diluted EPS▲26.6%
1.19
FY21→FY25CAGR +35.8%/yr
What the receipts whisper · what a headline number hides
Share count
+10.7%
54.2mn → 60.0mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$8.1M
▲737% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
12¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 29.8% → 36.5%. Net margin 11.7% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 767,530.0 | 609,780.0 | 516,013.0 | 493,612.0 | 427,787.0 | 379,513.0 | ▲18.2% | +12.6% |
Cost of revenue | 453,152.0 | 387,185.0 | 317,230.0 | 312,883.0 | 324,426.0 | 266,365.0 | ▲22.1% | +9.8% |
Gross profit | 314,378.0 | 222,595.0 | 198,783.0 | 180,729.0 | 103,361.0 | 113,148.0 | ▲12.0% | +18.4% |
Selling, general & admin | 162,012.0 | 140,063.0 | 124,963.0 | 124,236.0 | 100,306.0 | 88,559.0 | ▲12.1% | +12.1% |
Total operating expenses | 162,012.0 | 140,063.0 | 124,963.0 | 124,236.0 | 100,306.0 | 88,559.0 | ▲12.1% | +12.1% |
Operating incomefeeds ROC rank | 152,366.0 | 82,532.0 | 73,820.0 | 56,493.0 | 3,055.0 | 24,589.0 | ▲11.8% | +35.4% |
Other income, net | 2,819.0 | 10,439.0 | −3,032.0 | 1,427.0 | 7,786.0 | −360.0 | — | — |
Pretax income | 155,185.0 | 92,971.0 | 70,788.0 | 57,920.0 | 10,841.0 | 24,229.0 | ▲31.3% | +40.0% |
Income tax | 34,716.0 | 21,651.0 | 14,836.0 | 11,291.0 | 3,027.0 | 5,237.0 | ▲45.9% | +42.6% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 120,469.0 | 71,320.0 | 55,952.0 | 46,629.0 | 7,814.0 | 18,992.0 | ▲27.5% | +39.2% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 2.00 | 1.19 | 0.94 | 0.79 | 0.14 | 0.35 | ▲26.6% | +35.8% |
Diluted shares (mn) | 60.83 | 59.97 | 59.29 | 58.75 | 56.12 | 54.19 | ▲1.1% | +2.6% |
| Margins | ||||||||
Gross margin69th pct in Consumer Defensive | 41.0% | 36.5% | 38.5% | 36.6% | 24.2% | 29.8% | ▼2.0pp | +6.7pp |
Operating margin | 19.9% | 13.5% | 14.3% | 11.4% | 0.7% | 6.5% | ▼0.8pp | +7.1pp |
Net margin88th pct in Consumer Defensive | 15.7% | 11.7% | 10.8% | 9.4% | 1.8% | 5.0% | ▲0.9pp | +6.7pp |
† TTM = trailing four quarters through 2026-09-30.
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-18 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Vita Coco's revenue last fiscal year?
Vita Coco reported revenue of $609.8M in fiscal 2025, up 18.2% from fiscal 2024.
What was Vita Coco's net income?
Vita Coco reported net income of $71.3M in fiscal 2025, a net margin of 11.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

